MTOR and prostate carcinoma: Phosphorylation of S6K1 (P-S6K1) is a key biomarker of functional mTOR pathway activation and is abnormally expressed in prostate cancer, melanoma, breast cancer, lung cancer and colorectal cancer [16–19].